Literature DB >> 1894771

Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D.

T Nakamura1, T Ono, K Yoshimura, T Arao, S Kondo, M Ichihashi, A Matsumoto, Y Fujiwara.   

Abstract

A 43-year-old man with xeroderma pigmentosum, XP97TO, was allocated to complementation group D. He had had moderate photosensitivity at age 1 year and freckles by age 6 but no neurologic abnormalities. Nevertheless, his fibroblasts in culture had the XP-D phenotype. They showed a sevenfold hypersensitivity to killing by 254 nm ultraviolet radiation and a diminished level (29%) of unscheduled DNA synthesis. Phototesting revealed delayed maximum erythema at 72 hours after UVB exposure and a lowered minimal erythema dose. Lentigo maligna developed on the patient's face, and a rapidly growing malignant schwannoma was found on the left trigeminal nerve. This may be the first case of a peripheral nervous tissue neoplasm in xeroderma pigmentosum.

Entities:  

Mesh:

Year:  1991        PMID: 1894771     DOI: 10.1016/0190-9622(91)70202-d

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Malignant neurilemoma with xeroderma pigmentosum.

Authors:  Li Na Wang; Min Jian Ma; Ji Tong Shi
Journal:  BMJ Case Rep       Date:  2009-04-07

2.  Phenotype-specific adverse effects of XPD mutations on human prenatal development implicate impairment of TFIIH-mediated functions in placenta.

Authors:  Roxana Moslehi; Anil Kumar; James L Mills; Xavier Ambroggio; Caroline Signore; Amiran Dzutsev
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.